Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.100 |
None |
|
0 |
|
|
|
Eosinophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
325
|
23
|
0.100 |
None |
|
0 |
|
|
|
Persistent Polyclonal B-Cell Lymphocytosis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
8
|
|
0.300 |
None |
|
0 |
|
|
|
Recurrent respiratory infections
|
phenotype |
Infections; Respiratory Tract Diseases
|
Finding
|
318
|
7
|
0.100 |
None |
|
0 |
|
|
|
Decreased antibody level in blood
|
phenotype |
|
Finding
|
75
|
5
|
0.100 |
None |
|
0 |
|
|
|
Recurrent infections
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections; Musculoskeletal Diseases
|
Finding
|
127
|
14
|
0.100 |
None |
|
0 |
|
|
|
Splenomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
345
|
19
|
0.100 |
None |
|
0 |
|
|
|
Epstein-Barr Virus Infections
|
group |
Infections
|
Disease or Syndrome
|
384
|
72
|
0.010 |
None |
< 0.001 |
1 |
|
2001 |
2001 |
Familial primary gastric lymphoma
|
disease |
Digestive System Diseases; Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
121
|
2
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Mucosa-Associated Lymphoid Tissue Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
264
|
13
|
0.020 |
None |
0.500 |
2 |
|
2017 |
2018 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1043
|
127
|
0.600 |
None |
1.000 |
25 |
|
2006 |
2019 |
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1548
|
91
|
0.090 |
None |
1.000 |
9 |
|
2006 |
2019 |
Adult Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
504
|
46
|
0.070 |
None |
1.000 |
7 |
|
2008 |
2018 |
B-Cell Lymphomas
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1408
|
42
|
0.070 |
None |
1.000 |
7 |
|
2005 |
2020 |
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY
|
disease |
|
Disease or Syndrome
|
2
|
5
|
0.710 |
strong |
1.000 |
6 |
5
|
2012 |
2017 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
|
2008 |
2019 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.050 |
None |
1.000 |
5 |
|
2006 |
2016 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.050 |
None |
1.000 |
5 |
|
2006 |
2016 |
Dermatitis, Atopic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
751
|
232
|
0.440 |
None |
1.000 |
4 |
|
2012 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
Eczema
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
863
|
368
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2019 |
Primary immune deficiency disorder
|
group |
Immune System Diseases
|
Disease or Syndrome
|
93
|
23
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2018 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2019 |
IMMUNODEFICIENCY 11
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.700 |
strong |
1.000 |
3 |
3
|
2013 |
2015 |
Combined immunodeficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
86
|
11
|
0.320 |
strong |
1.000 |
3 |
|
2013 |
2018 |